Trade Summary

6 days ago, Lechleider Robert, serving as Chief Medical Officer at Immunome Inc. (IMNM), sold 55,000 shares at $19.85 per share, for a total transaction value of $1,091,662.00. Following this transaction, Lechleider Robert now holds 15,805 shares of IMNM.

This sale represents a 77.68% decrease in Lechleider Robert's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 4:52 PM ET, 4 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.